| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 05.11. | Concept Life Sciences Appoints Dean Bornilla as Chief Commercial Officer | ||
| 04.11. | Agilent Completes $240M Proscia Acquisition | ||
| 04.11. | Minghui, ASKA Agree to License and Commercialize TED Treatment in Japan | ||
| 04.11. | Kimia and CStone Partnership Moves Oncology Asset to Clinical Development | ||
| 04.11. | SK Biopharma Seeks FDA Expansion for Cenobamate | ||
| 04.11. | AdvanCell Names Andy Porter Chief People Officer | ||
| 04.11. | ARTHEx Biotech Names Christian Freitag Chief Medical Officer | ||
| 04.11. | Circular Genomics, PharmatrophiX Partner on Alzheimer's Biomarker Research | ||
| 03.11. | AGC Biologics Adds Copenhagen Site to Deal with Global Pharma Company | ||
| 03.11. | Shilpa CDMO Invests $50M in Peptide Manufacturing | ||
| 03.11. | Pfizer Removes Interim Tag, Makes Cecile Guegan CFO and EVP | ||
| 03.11. | Lonza to Acquire Merck KGaA's CDMO Business | ||
| 02.11. | Catalent Appoints Wetteny Joseph as Pharma and Consumer Health President | ||
| 02.11. | AbbVie, Brise Migraine Deal Hits Early Milestones | ||
| 02.11. | OncoC4 Welcomes Dan Janiak as Chief Business Officer | ||
| 02.11. | PerkinElmer Appoints Dr. Kaveh Kahen as President of Analytical & Testing Solutions | ||
| 02.11. | Coriolis Pharma Names Teun van der Heide New CEO | ||
| 02.11. | Kindeva Names Daniel Couto EVP of Inhalation & Specialty Drug Delivery | ||
| 02.11. | Fresenius, WuXi Biologics Sign Biosimilars Deal | ||
| 30.10. | Edison Scientific Inks AI Deal with Pfizer | ||
| 30.10. | Cambrex Breaks Ground on $120M Expansion at Charles City Site | ||
| 30.10. | Pace Life Sciences Completes EMA GMP Inspection at Lebanon, NJ Facility | ||
| 29.10. | BioMarin, GC Biopharma, Hanmi Pharm to Collaborate on Fabry Disease Treatment | ||
| 29.10. | Codis Completes Redundant UK Facility Demolition, Starts Construction on PSD-4 Expansion | ||
| 29.10. | Sanofi Launches Phase III Flu-COVID Vaccine Trial in Europe, Earning Novavax $125M |